Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005
- PMID: 21030112
- DOI: 10.1016/j.jhin.2010.07.015
Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005
Abstract
A population-based study was undertaken to determine the short term risk of death in English patients diagnosed with meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia. All patients with an MRSA-positive blood culture taken in 2004 and 2005 in England identified through routine surveillance were matched to the national registry of deaths. The study found an overall case fatality (all-cause) within 7 days of MRSA-positive blood culture diagnosis of 20%, rising to 38% within 30 days. Risk of death was highest on the day subsequent to the blood specimen being drawn (4%). Seven-day case fatality rates in women were 16% higher than for men (odds ratio: 1.16; 95% confidence interval: 1.04-1.29), although no significant difference was discernable by day 30. Risk of death increased with rising age, with 28% (425/1513) of patients aged ≥85 years dying within 7 days and 57% (859/1513) within 30 days. A seasonal pattern in case fatality rates was evident, highest in the winter and lowest in the summer. The age-standardised mortality ratios within the first week were 180 and 225 times as high for men and women, respectively, as for the general population. This declined rapidly after 10 weeks to approximately 9 for both sexes. An estimated 5.53 deaths per 100,000 population followed MRSA bacteraemia in 2004 and 2005, although no inference on causality or attributable mortality could be made through this study. The stable, elevated risk of death observable after 10 weeks compared with that in the general population gave an indication of the background risk of death unrelated to MRSA infection.
Copyright © 2010 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.J Antimicrob Chemother. 2010 Aug;65(8):1792-8. doi: 10.1093/jac/dkq188. Epub 2010 May 28. J Antimicrob Chemother. 2010. PMID: 20511366
-
Enhanced surveillance of meticillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital.J Hosp Infect. 2006 Aug;63(4):365-73. doi: 10.1016/j.jhin.2005.12.009. Epub 2006 Jun 9. J Hosp Infect. 2006. PMID: 16765481
-
Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.J Hosp Infect. 2011 Oct;79(2):108-14. doi: 10.1016/j.jhin.2011.04.023. Epub 2011 Jul 8. J Hosp Infect. 2011. PMID: 21741724
-
Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years.J Antimicrob Chemother. 2012 Apr;67(4):802-9. doi: 10.1093/jac/dkr561. Epub 2012 Jan 4. J Antimicrob Chemother. 2012. PMID: 22223229 Review.
-
Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England.J Antimicrob Chemother. 2009 Sep;64 Suppl 1:i11-7. doi: 10.1093/jac/dkp260. J Antimicrob Chemother. 2009. PMID: 19675013 Review.
Cited by
-
PEGylated Oligothioetheramide Prodrugs Activated by Host Serum Proteases.Chembiochem. 2021 Sep 2;22(17):2697-2702. doi: 10.1002/cbic.202100146. Epub 2021 Jul 13. Chembiochem. 2021. PMID: 34227209 Free PMC article.
-
Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.Ann Clin Microbiol Antimicrob. 2016 Feb 9;15:7. doi: 10.1186/s12941-016-0122-8. Ann Clin Microbiol Antimicrob. 2016. PMID: 26860463 Free PMC article.
-
A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.Crit Care Med. 2016 Apr;44(4):671-9. doi: 10.1097/CCM.0000000000001465. Crit Care Med. 2016. PMID: 26540400 Free PMC article.
-
Staphylococcus aureus bacteraemia and mortality: a population-based study in Olmsted County, Minnesota, from 2006 to 2020.Infect Dis (Lond). 2023 Jan;55(1):1-8. doi: 10.1080/23744235.2022.2123561. Epub 2022 Sep 24. Infect Dis (Lond). 2023. PMID: 36151989 Free PMC article.
-
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis.Infect Dis Ther. 2020 Jun;9(2):325-339. doi: 10.1007/s40121-020-00292-8. Epub 2020 Apr 4. Infect Dis Ther. 2020. PMID: 32248513 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical